139 related articles for article (PubMed ID: 11398237)
1. Is immunoproliferative small intestinal disease uncommon in India?
Ghoshal UC; Chetri K; Banerjee PK; Choudhuri G; Pal BB; Dabadghao S; Dhar K; Naik S; Naik SR
Trop Gastroenterol; 2001; 22(1):14-7. PubMed ID: 11398237
[TBL] [Abstract][Full Text] [Related]
2. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
Nair S; Mathan M; Ramakrishna BS; Mathan VI
J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
[TBL] [Abstract][Full Text] [Related]
3. Pigmented nails and Strongyloides stercoralis infestation causing clinical worsening in a patient treated for immunoproliferative small intestinal disease: two unusual observations.
Ghoshal UC; Saha J; Ghoshal U; Ray BK; Santra A; Naik S; Mazumder DN
J Diarrhoeal Dis Res; 1999 Mar; 17(1):43-5. PubMed ID: 10892497
[TBL] [Abstract][Full Text] [Related]
4. Immunoproliferative small intestinal disease in Greece: presentation of 13 cases including two from Albania.
Economidou I; Manousos ON; Triantafillidis JK; Vaslamatzis MM; Zafiropoulou R; Papadakis T
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1029-38. PubMed ID: 16894320
[TBL] [Abstract][Full Text] [Related]
5. Immunoproliferative small intestinal disease (IPSID) in Thailand.
Pramoolsinsap C; Kurathong S; Atichartakarn V; Nitiyanand P
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):11-7. PubMed ID: 8362283
[TBL] [Abstract][Full Text] [Related]
6. [Primary immunoproliferative small intestinal disease].
Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R
G E N; 1995; 49(3):238-42. PubMed ID: 8598264
[TBL] [Abstract][Full Text] [Related]
7. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
Shih LY; Liaw SJ; Dunn P; Kuo TT
J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
[TBL] [Abstract][Full Text] [Related]
8. Should we suppress the antigenic stimulus in IPSID for lifelong?
Celik AF; Pamuk GE; Pamuk ON; Uzunismail H; Oktay E; Doğusoy G
Am J Gastroenterol; 2000 Nov; 95(11):3318-20. PubMed ID: 11095373
[No Abstract] [Full Text] [Related]
9. Immunoproliferative small intestinal disease (IPSID).
Pervez S; Mumtaz K; Ullah SS; Akhtar N; Ali N; Aaqil H
J Coll Physicians Surg Pak; 2011 Jan; 21(1):57-8. PubMed ID: 21276391
[TBL] [Abstract][Full Text] [Related]
10. Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease.
Hubmann R; Kaiser W; Radaszkiewicz T; Fridrik M; Zazgornik I
Z Gastroenterol; 1995 Apr; 33(4):209-13. PubMed ID: 7793120
[TBL] [Abstract][Full Text] [Related]
11. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
Zahner J; Kirchner T; Ott G; Schneider W
Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of malabsorption in India--tropical sprue is still the leader.
Dutta AK; Balekuduru A; Chacko A
J Assoc Physicians India; 2011 Jul; 59():420-2. PubMed ID: 22315745
[TBL] [Abstract][Full Text] [Related]
16. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
[TBL] [Abstract][Full Text] [Related]
17. [Immunoproliferative disease of the small intestine. A rare differential diagnosis of Crohn's disease].
Pohl C; Eidt S; Ziegenhagen D; Kruis W
Dtsch Med Wochenschr; 1991 Aug; 116(34):1265-9. PubMed ID: 1874129
[TBL] [Abstract][Full Text] [Related]
18. Immunoproliferative small intestinal disease, two cases in the Northern Territory.
Healey T; Olver I; Selva-Nayagam S
Intern Med J; 2002; 32(1-2):47-9. PubMed ID: 11783675
[No Abstract] [Full Text] [Related]
19. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
Mounier N; Gisselbrecht C; Brière J; Haioun C; Feugier P; Offner F; Recher C; Stamatoullas A; Morschhauser F; Macro M; Thieblemont C; Sonet A; Fabiani B; Reyes F;
J Clin Oncol; 2004 Jul; 22(14):2826-34. PubMed ID: 15254050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
